###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License () which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM</italic>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 523 526 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 680 684 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 696 699 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 699 703 699 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunological functions, associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ionizing radiation. Although ataxia-telangiectasia mutated (ATM) heterozygous deficiency has been proposed to increase susceptibility to breast cancer, some studies have not found excess risk. In experimental animals, increased susceptibility to breast cancer is not observed in the Atm heterozygous deficient mice (Atm+/-) carrying a knockout null allele. In order to determine the effect of Atm heterozygous deficiency on mammary tumourigenesis, we generated a series of Atm+/- mice on the p53+/- background with a certain predisposition to spontaneous development of mammary carcinomas, and we examined the development of the tumours after X-irradiation.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 13 17 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 80 82 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 112 113 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
BALB/cHeA-p53+/- mice were crossed with MSM/Ms-Atm+/- mice, and females of the F1 progeny ([BALB/cHeA x MSM/Ms]F1) with four genotypes were used in the experiments. The mice were exposed to X-rays (5 Gy; 0.5 Gy/min) at age 5 weeks.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 451 455 451 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 604 609 <span type="species:ncbi:10090">mouse</span>
We tested the effect of haploinsufficiency of the Atm gene on mammary tumourigenesis after X-irradiation in the p53+/- mice of the BALB/cHeA x MSM/Ms background. The singly heterozygous p53+/- mice subjected to X-irradiation developed mammary carcinomas at around 25 weeks of age, and the final incidence of mammary carcinomas at 39 weeks was 31% (19 out of 61). The introduction of the heterozygous Atm knockout alleles into the background of the p53+/- genotype significantly increased the incidence of mammary carcinoma to 58% (32 out of 55) and increased the average number of mammary carcinomas per mouse. However, introduction of Atm alleles did not change the latency of development of mammary carcinoma.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 105 109 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Our results indicate a strong enhancement in mammary carcinogenesis by Atm heterozygous deficiency in p53+/- mice. Thus, doubly heterozygous mice represent a useful model system with which to analyze the interaction of heterozygous genotypes for p53, Atm and other genes, and their effects on mammary carcinogenesis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 883 887 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1148 1152 1148 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 778 786 <span type="species:ncbi:9606">patients</span>
Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunologic functions, and is associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ionizing radiation [1,2]. ATM (ataxia-telangiectasia mutated) heterozygous deficiency has been proposed to increase susceptibility to breast cancer [3-7]. However, those early studies were limited by the lack of reliable assays with which to identify carriers [8]. In fact, in a later study a lack of association of heterozygous ATM mutations with early onset of breast cancer was found [9]. More recent epidemiological studies suggested that missense mutation in the ATM gene, rather than a protein-truncating mutation, which accounts for the majority of mutations in patients with ataxia-telangiectasia, confers increased risk for breast cancer [10]. Thus, cancer risk in ATM heterozygotes varies depending on the mutation type (i.e. some missense-type mutations are associated with early onset of breast carcinoma whereas truncation-type mutations are not) [11,12]. Recently, epidemiological studies on excess risk for breast cancer in ATM heterozygosity were reported [13].
###end p 11
###begin p 12
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 314 320 <span type="species:ncbi:9606">humans</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 531 537 <span type="species:ncbi:9606">humans</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
In experimental animals, no tumours were observed in Atm heterozygous mice carrying a knockout null allele of Atm [14]. In contrast, Atm knock-in heterozygous mice harbouring an in-frame deletion corresponding to the human mutation exhibit increased susceptibility to a wide variety of tumours [14]. Thus, data in humans and mice suggest that the type of Atm mutation determines susceptibility to cancer in heterozygous individuals. Heterozygosity for a null knockout allele of Atm in mice and protein-truncating alleles of ATM in humans was thought not to increase susceptibility to mammary cancer. On the other hand, haploinsufficiency at the Atm gene has a phenotype of increased sensitivity to ionizing radiation in mice [15].
###end p 12
###begin p 13
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 575 579 575 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 590 594 590 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 605 609 605 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 612 615 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 621 624 621 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 624 628 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 628 631 628 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">Mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
In contrast to the Atm gene, the p53 null allele exhibits haploinsufficiency for the development of tumours in mice, mainly lympho-haematopoietic malignancies [16,17]. The p53 heterozygotes of BALB/c genetic background develop mammary tumours [18-20]. Mice doubly null for the p53 and Atm genes were reported to exhibit a dramatic acceleration in tumour formation relative to singly null mice, indicating that the genes cooperate in a significant manner to prevent tumourigenesis [21]. However, the authors noted no mammary carcinoma in any of the four genotypes studied (p53+/+ Atm-/-, p53+/- Atm-/-, p53-/- Atm+/-, and p53-/- Atm-/-). Thus, the significance of haploinsufficiency of the Atm null allele in mammary carcinogenesis is obscure at present.
###end p 13
###begin p 14
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
In order to determine the effect of Atm heterozygous deficiency on mammary tumourigenesis, we generated a series of Atm+/- mice on the background of p53+/- mice with a certain predisposition to spontaneous development of mammary carcinomas, and we examined the development of tumours after X-irradiation. Our results indicate a strong enhancement of mammary carcinogenesis in the Atm heterozygous deficient mice under the p53 heterozygous deficiency.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 16
###begin p 17
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 369 372 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 372 378 372 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm1Awb</italic>
###xml 372 381 372 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm1Awb</italic>/+ </sup>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 570 574 570 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 604 607 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 607 611 607 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 637 639 637 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 669 670 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 701 705 701 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 705 708 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 708 711 708 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 716 720 716 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 723 726 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 731 735 731 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 738 742 738 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 746 749 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 749 753 749 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 753 756 753 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 756 759 756 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
The p53 targeted allele generated by Donehower and coworkers [22] was introduced into the BALB/cHeA mouse at The Netherlands Cancer Institute (Amsterdam). The p53 heterozygous deficient mice (p53+/-) were repeatedly backcrossed to BALB/cHeA mice more than 30 times, and maintained at the animal facility of Osaka Prefecture University. The Atm targeted mouse (129/SvEv-Atmtm1Awb/+ mouse) was originally generated in the Jackson Laboratory [23]. The Atm heterozygous deficient mice (Atm+/-) were repeatedly backcrossed more than 10 times to MSM/Ms mice. The BALB/cHeA-p53+/- mice were crossed with MSM/Ms-Atm+/- mice, and females of the F1 progeny ([BALB/cHeA x MSM/Ms]F1) with four genotypes (i.e. p53+/- Atm+/-, p53+/- Atm+/+, p53+/+ Atm+/- and p53+/+ Atm+/+) were used in the experiments. The conditions for breeding were described previously [24].
###end p 17
###begin title 18
X-irradiation
###end title 18
###begin p 19
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were exposed at 5 weeks of age to X-rays (5 Gy; 260 kV, 12.0 mA, 0.3 mm Cu + 0.5 mm Al filter; 0.5 Gy/min) from an X-ray generator (Radioflex 350; Rigaku Industrial Co., Takatsuki, Japan). All animal experiments were carried out in accordance with the standards relating to the care and management of experimental animals (Japan) and Osaka Prefecture University's guidelines for animal care and use.
###end p 19
###begin title 20
Histopathological examination
###end title 20
###begin p 21
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Moribund mice were killed by cervical dislocation for autopsy. In cases of thymic lymphoma, the enlarged thymuses were examined as previously described [25]. In tumour-bearing mice the tumours were fixed in 10% buffered formalin, processed histologically, and stained with haematoxylin and eosin. The processed tumour specimens were evaluated by medical and veterinary pathologists using the Annapolis guidelines established by Cardiff and coworkers [26].
###end p 21
###begin title 22
DNA isolation and genotyping
###end title 22
###begin p 23
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 518 521 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
Normal and mammary carcinoma tissues were removed. Isolation of DNA, PCR amplification, electrophoresis of PCR products and assessment of allelic losses were performed according to a procedure described previously [24]. Genotypes for the wild-type and targeted alleles of p53 and Atm genes were determined by analyzing the PCR products for these alleles. Amplification for the p53 alleles was done as described elsewhere [27]. The wild-type and the targeted alleles of the p53 gene were amplified by PCR using primers p53-4F (5'-CGACCTCCGTTCTCTCTCCTCTCTT-3') and p53-6R (5'-AGACGCACAAACCAAAACAAAATTACA-3'), and primers p53-NF (5'-GCCTTCTATCGCCTTCTTGACGAGT-3') and p53-6R, respectively. Similarly, amplification of the wild-type and the targeted allele of the Atm gene were performed by using primers IMR0640F (5'-GCTGCCATACTTGATCCATG-3') and IMR0641R (5'-TCCGAATTTGCAGGAGTTG-3'), and primers IMR0640F and AtmNeo410R (5'-CGGTGGATGTGGAATGTGTG-3'), respectively.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 119 121 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Statistical significance was evaluated for the incidence of mammary carcinoma and number of carcinomas per mouse by chi2 analysis and Mann-Whitney U-test, respectively. Comparison of latency in mammary carcinoma development was examined by unpaired Student's t-test.
###end p 25
###begin title 26
Results and discussion
###end title 26
###begin title 27
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Histopathological features of tumours developed in F1 mice doubly heterozygous for p53 and Atm null alleles
###end title 27
###begin p 28
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 164 168 164 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 257 274 257 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a,1b,1c,1d,1e,1f</xref>
###xml 385 390 385 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a,1b</xref>
###xml 468 479 468 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c,1d,1e,1f</xref>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 634 638 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 644 649 644 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c,1d</xref>
###xml 655 658 655 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 658 662 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 673 678 673 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1e,1f</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
Mammary carcinomas occurred in BALB/c mice of the p53+/- genotype, and tumours of similar macroscopic morphologies were also observed in the (BALB/c x MSM/Ms)F1-p53+/- mice. The histological features of these tumours in the mammary glands are shown in Fig. 1a,1b,1c,1d,1e,1f, which indicates that they are adenocarcinomas. The histopathology of the tumours in nonirradiated mice (Fig. 1a,1b) exhibited more hyperplastic lesions than did those in irradiated mice (Fig. 1c,1d,1e,1f), but basically there were no marked differences between the two groups. There was also no remarkable difference in histopathological features between Atm+/- (Fig. 1c,1d) and Atm+/+ mice (Fig. 1e,1f) in the irradiated groups. These tumours formed glands lined by highly pleomorphic cells exhibiting frequent mitosis, and were classified as glandular adenocarcinomas, high grade according to the Annapolis Pathology Classification [26].
###end p 28
###begin p 29
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1g</xref>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1h</xref>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
Lymphomas (Fig. 1g), mainly thymic lymphomas, were efficiently induced by exposure to X-rays, regardless of p53 and Atm genotype, although only a few lymphomas were observed in nonirradiated mice. Ovarian carcinomas, osteosarcomas (Fig. 1h) and hepatomas developed spontaneously. Squamous cell carcinomas, basal cell carcinomas, histiocytic sarcomas and granulocytic leukaemias were also observed in irradiated mice.
###end p 29
###begin title 30
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Spontaneous tumour development in mice with four genotypes for p53 and Atm
###end title 30
###begin p 31
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 80 84 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 197 201 197 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 201 204 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 204 208 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 242 246 242 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 384 387 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 387 391 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 394 398 394 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 441 445 441 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 448 452 448 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 514 517 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 517 521 517 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 525 528 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 528 532 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 543 545 543 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 630 633 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 633 637 633 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 911 913 911 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 963 966 963 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 966 970 966 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 970 973 970 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 973 977 973 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 989 992 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 992 996 992 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 996 999 996 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 999 1003 999 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1119 1120 1119 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1180 1184 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1229 1231 1229 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1241 1244 1241 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1244 1248 1244 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1261 1264 1261 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 1264 1268 1264 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1272 1275 1272 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 1275 1279 1275 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1003 1007 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
Twenty-eight p53+/- Atm+/-, 22 p53+/- Atm+/+, 11 p53+/+ Atm+/- and 25 p53+/+ Atm+/+ mice were examined for spontaneous development of tumours until age 26 months (113 weeks). Fourteen out of 28 p53+/- Atm+/- mice (50%) and seven out of 22 p53+/- Atm+/+ mice (32%) developed mammary carcinomas during the period of observation (Table 1, Fig. 2). The incidence of mammary carcinomas in p53+/- Atm+/- mice appeared to be higher than that in p53+/- Atm+/+ mice, but the incidences did not differ significantly between Atm+/- and Atm+/+ genotypes (P = 0.32, by Fisher's exact probability test). Among the tumours that developed in the p53+/- mice, mammary carcinoma were the most common. These mammary carcinomas were mainly observed at 41-77 weeks after birth (Fig. 2). No significant difference in latency in the nonirradiated groups was observed between doubly heterozygous mice and p53 singly heterozygous mice (P = 0.47, by unpaired Student's t-test). None of 11 p53+/+ Atm+/- mice and 25 p53+/+ Atm+/+ mice developed mammary carcinomas. Several lymphomas and a few other tumours developed in the four genotypes (Table 1). Thus, mammary carcinoma development depended strongly on p53 heterozygous deficiency in (BALB/c x MSM/Ms)F1 mice, and p53+/- mice of both Atm+/+ and Atm+/- genotypes developed mammary carcinoma.
###end p 31
###begin title 32
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Enhancement of mammary carcinogenesis in Atm heterozygous deficient mice by X-irradiation
###end title 32
###begin p 33
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 109 113 109 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 161 165 161 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 179 182 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 292 296 292 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 299 303 299 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 333 337 333 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 401 405 401 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 534 538 534 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 541 545 541 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 576 580 576 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 583 587 583 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 709 713 709 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 716 720 716 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 772 776 772 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 779 783 779 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 790 792 790 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 808 810 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 866 869 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 869 873 867 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 873 876 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 876 880 874 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 983 986 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 986 990 984 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 990 993 988 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 993 997 991 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1060 1061 1058 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1122 1125 1120 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1125 1129 1123 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1129 1132 1127 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 1132 1136 1130 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1181 1184 1179 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1184 1188 1182 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1188 1191 1186 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 1191 1195 1189 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1201 1203 1199 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1244 1248 1242 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1328 1332 1326 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1382 1384 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1409 1413 1407 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1423 1426 1421 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 1426 1429 1424 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1484 1488 1482 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1549 1553 1547 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 1715 1719 1713 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1757 1760 1755 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1760 1764 1758 1762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1785 1789 1783 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1858 1862 1856 1860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1945 1949 1943 1947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 923 928 <span type="species:ncbi:10090">mouse</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1040 1045 <span type="species:ncbi:10090">mouse</span>
###xml 1109 1114 <span type="species:ncbi:10090">mouse</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1354 1358 <span type="species:ncbi:10090">mice</span>
###xml 1444 1448 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">Mice</span>
###xml 1492 1498 <span type="species:ncbi:9606">humans</span>
To test the effect of haploinsufficiency of the Atm gene on mammary carcinogenesis after X-irradiation in p53+/- mice, 55 p53+/- Atm+/-, 61 p53+/- Atm+/+, 47 p53+/+ Atm+/- and 53 p53+/+ Atm+/+ mice (for a total of 216 mice) were exposed to X-rays (5 Gy) at age 5 weeks. Only one out of 53 p53+/+ Atm+/+ mice and none of 47 p53+/+ Atm+/- mice developed mammary carcinoma, indicating that almost all p53+/+ mice fail to develop mammary carcinomas, despite X-irradiation and irrespective of Atm gene status. In contrast, 32 out of 55 p53+/- Atm+/- mice (58%) and 19 out of 61 p53+/- Atm+/+ mice (31%) developed mammary carcinomas (Table 2, Fig. 2). The proportion of mice developing mammary carcinomas in the p53+/- Atm+/- group was significantly greater than that in the p53+/- Atm+/+ group (P = 0.0034, by chi2 test). A total of 52 mammary carcinomas developed in 55 p53+/- Atm+/- mice (average number of mammary carcinomas/mouse = 0.95), whereas 28 mammary carcinoma developed in 61 p53+/- Atm+/+ mice (average number of mammary carcinomas/mouse = 0.46; Table 2). The average number of mammary carcinomas per mouse in the p53+/- Atm+/- group was significantly greater than that in p53+/- Atm+/+ mice (P = 0.0052, by Mann-Whitney U-test). Thus, Atm heterozygous deficiency enhanced development of mammary carcinoma in irradiated p53 heterozygous knockout mice. Spring and coworkers [14] observed no tumours in Atm knockout (Atm+/-) heterozygous mice. Mice bearing a knockout allele of Atm and humans carrying a mutant allele of truncated type in the ATM gene have been shown not to have obviously elevated susceptibility to mammary carcinogenesis. Our findings show that heterozygosity for a null knockout allele of Atm enhances mammary carcinogenesis under p53+/- status, although the Atm mutation is not a dominant-negative type. Heterozygous deficiency of p53 might make clear the effect on mammary carcinogenesis of haploinsufficiency in the Atm gene.
###end p 33
###begin p 34
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 360 363 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 363 367 357 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 367 370 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 370 374 364 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 378 381 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 381 385 375 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 385 388 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 388 392 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 595 596 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 601 602 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 643 646 637 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 646 650 640 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 650 653 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 653 657 647 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 766 769 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 769 773 763 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 773 776 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 776 780 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
These mammary carcinomas were observed significantly earlier (at 18-38 weeks after irradiation; i.e. 23-43 weeks of age) than in the nonirradiated group (age 41-75 weeks; Fig. 2). In particular, mammary carcinomas frequently developed 23-28 weeks after irradiation. The mean (+/- standard deviation) latency periods were 32.6 +/- 4.8 and 29.8 +/- 3.6 weeks in p53+/- Atm+/- and p53+/- Atm+/+ mice, respectively. Thus, X-irradiation at 5 Gy at age 5 weeks considerably shortened the latency period of mammary carcinoma development in these two groups with different genotypes. As shown in Tables 1 and 2, the incidences of mammary carcinoma in p53+/- Atm+/- mice were 58% (32 out of 55) and 50% (14 out of 28) in irradiated and nonirradiated groups, respectively; in p53+/- Atm+/+ mice the incidence in the irradiated group was 31% (19 out of 61) and that in the nonirradiated group was 32% (7 out of 22). The incidence of mammary carcinoma for each genotype was similar between irradiated and non-irradiated groups. Thus, irradiation may not elevate the incidence of the tumours.
###end p 34
###begin p 35
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 82 86 82 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 494 496 494 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 658 661 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 661 665 661 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 668 672 668 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
Altogether, irradiation markedly hastened mammary carcinoma development in the p53+/- mice, in which mammary carcinomas developed spontaneously. Furthermore, irradiation also induced lymphomas, mainly thymic lymphomas, in all four genotypes of mice. The incidence of the lymphomas did not differ significantly among the four groups, with different genotypes for p53 and Atm genes. A high incidence of thymic lymphoma was observed in previous studies performed using p53 heterozygous deficient F1 mice [17,28]. In the present study an extremely high incidence of tumours, most of which were mammary carcinomas and thymic lymphomas, was observed in irradiated p53+/- Atm+/- mice.
###end p 35
###begin title 36
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
Status of wild-type alleles of p53 and Atm in mammary carcinoma
###end title 36
###begin p 37
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 207 211 207 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 359 363 359 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 366 370 366 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 536 540 536 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 579 580 579 580 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 600 604 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 739 743 739 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 805 808 805 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 808 812 808 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
The wild-type alleles of the p53 and Atm genes were examined in mammary carcinoma tissue from heterozygous mice. The wild-type p53 allele was lost in 25 (96%) out of 26 mammary carcinomas from irradiated p53+/- mice and in all of 15 mammary carcinomas from nonirradiated p53+/- mice, regardless of Atm gene status. Only one mammary carcinoma in irradiated p53+/+ Atm+/+ mice (Table 2) was found to retain the p53 wild-type allele. On the other hand, wild-type Atm allele was preserved in all of 17 mammary carcinomas from irradiated Atm+/- mice and in all of 10 mammary carcinomas from irradiated Atm+/+ mice, regardless of p53 gene status. Wild-type Atm allele was also retained in nine out of 10 mammary carcinomas from nonirradiated Atm+/- mice and in all of five mammary carcinomas from nonirradiated Atm+/+ mice. These results suggest that the homozygous loss of the p53 allele was a necessary condition for the development of mammary carcinomas, whereas the Atm null allele exhibited haploinsufficiency.
###end p 37
###begin p 38
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nbn </italic>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBS1</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nbn </italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nbn </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p27 </italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p27 </italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 663 666 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 915 919 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1265 1269 1265 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1332 1336 1332 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1346 1350 1346 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1518 1522 1518 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1550 1552 1550 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1699 1702 1699 1702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 937 943 <span type="species:ncbi:9606">humans</span>
###xml 1054 1060 <span type="species:ncbi:9606">humans</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
###xml 1552 1556 <span type="species:ncbi:10090">mice</span>
Haploinsufficiency for tumour development was reported for the Nbn knockout mice, the mouse homologue of NBS1. Heterozygosity for the Nbn knockout allele rendered the mice susceptible to tumour development, yet the Nbn wild-type allele was fully retained in all 12 tumours examined [29]. p27 heterozygotes are also predisposed to tumours in multiple tissues when challenged with irradiation or a chemical carcinogen, and in the developed tumours the remaining wild-type allele is neither mutated nor silenced, indicating that p27 is haploinsufficient for tumour suppression [30]. In that study, heterozygous Atm knockout enhanced mammary carcinoma development in p53-heterozygous deficient mice, but the effect of Atm deficiency was not as profound. A previous study showed that heterozygosity for the Atm knockout allele did not enhance tumour development but that dominant-negative type missense mutations in the Atm gene did [14]. In humans, heterozygosity of the truncation-type mutations, which represent the majority of Atm mutations that occur in humans, had no effect on carcinogenesis, suggesting that enhancement in tumourigenesis depends strongly on mutation type. However, in the present study we demonstrated that haploinsufficiency does occur for the Atm null allele in combination with heterozygous deficiency in the p53 gene. The p53 heterozygous deficient BALB/c mice, which developed mammary carcinomas early and efficiently, may represent a useful model for the study of effects of genes other than Atm on mammary carcinogenesis. F1 mice between different subspecies may also provide an experimental system for precise genome-wide allelotype analysis of genes that cooperate with p53.
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 551 554 551 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 554 558 554 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 845 849 845 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 861 864 861 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 864 868 864 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 973 976 973 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 976 980 976 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1032 1036 1032 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1185 1189 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1239 1243 1239 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 1478 1481 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1483 1487 1483 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
###xml 1373 1377 <span type="species:ncbi:10090">mice</span>
Tumourigenesis is strongly enhanced in mice with homogeneous deficiency in the p53 or Atm gene. In the present study we tested the effect of haploinsufficiency of the Atm gene on mammary tumourigenesis after X-irradiation in p53+/- mice of the BALB/cHeA x MSM/Ms background. Singly heterozygous p53+/- mice X-irradiated (5 Gy) at age 5 weeks developed mammary carcinomas at around 25 weeks of age, and the final incidence of mammary carcinoma at 39 weeks was 31% (19 out of 61). Introduction of the heterozygous Atm alleles into the background of the p53+/- genotype significantly increased the incidence of mammary carcinomas to 58% (32 out of 55) and increased the average number of mammary carcinomas per mouse. However, it apparently did not change the latency of mammary carcinoma development. In nonirradiated mice, introduction of the Atm+/- allele into p53+/- mice also tended to increase spontaneous incidence of mammary carcinoma. In contrast, almost none of the p53+/+ mice developed mammary carcinoma, regardless of the Atm gene status and whether mice were subjected to irradiation. In almost all of the spontaneous and radiation-induced mammary carcinomas, the wild-type p53 allele was found to be lost whereas the wild-type Atm allele was retained, suggesting haploinsufficiency of the latter gene in mammary carcinoma development. Thus, doubly heterozygous mice represent a useful model system with which to analyze the interaction of heterozygous genotypes for p53, Atm and other genes and their effect on mammary carcinogenesis.
###end p 40
###begin title 41
Abbreviations
###end title 41
###begin p 42
PCR = polymerase chain reaction.
###end p 42
###begin title 43
Competing interests
###end title 43
###begin p 44
The author(s) declare that they have no competing interests.
###end p 44
###begin title 45
Authors' contributions
###end title 45
###begin p 46
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
SU carried out design of the study, observed mammary carcinoma development and other diseases, and drafted a manuscript. KF prepared tissue specimens and conducted histopathological examinations (veterinarian). SI carried out DNA isolation and genotyping of mice. NM carried out X-irradiation of mice and statistical analysis. MT performed DNA isolation and genotyping of mice. DH carried out production of heterozygous deficient mice. CS participated in designing the study and discussion of data on mammary carcinoma development. SH contributed to histopathological examination. SI conducted histopathological examinations (medical doctor). ON participated in discussion of data and contributed to preparation of the final manuscript. MO carried out design of the study and X-irradiation, and wrote the final manuscript. All authors read and approved the final manuscript.
###end p 46
###begin title 47
Acknowledgements
###end title 47
###begin p 48
We are grateful to Mr M Ikeda and Mr U Ujihara for their skilful animal care. This study was performed in part by Grants-in-Aid for scientific research No. 13480172 (to MO) and No. 14580571 (to NM) from the Ministry of Education, Science, Sports and Culture of Japan, and a Grant-in-Aid from the Japan Atomic Energy Research Institute under contract to the Nuclear Safety Research Association.
###end p 48
###begin article-title 49
Ataxia-telangiectasia
###end article-title 49
###begin article-title 50
The genetic defect in ataxia-telangiectasia
###end article-title 50
###begin article-title 51
Breast and other cancers in families with ataxia-telangiectasia
###end article-title 51
###begin article-title 52
Incidence of cancer in 161 families affected by ataxia-telangiectasia
###end article-title 52
###begin article-title 53
Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
###end article-title 53
###begin article-title 54
Cancer risk in heterozygotes for ataxia-telangiectasia
###end article-title 54
###begin article-title 55
###xml 10 18 <span type="species:ncbi:9606">patients</span>
Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries
###end article-title 55
###begin article-title 56
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
ATM heterozygosity and cancer risk
###end article-title 56
###begin article-title 57
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
Heterozygous ATM mutations do not contribute to early onset of breast cancer
###end article-title 57
###begin article-title 58
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
ATM missense mutations are frequent in patients with breast cancer
###end article-title 58
###begin article-title 59
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations
###end article-title 59
###begin article-title 60
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATM </italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history
###end article-title 60
###begin article-title 61
Workshop on the epidemiology of the ATM gene: Impact on breast cancer risk and treatment, present status and future focus, Lillehammer, Norway, 29 June 2002
###end article-title 61
###begin article-title 62
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer
###end article-title 62
###begin article-title 63
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice
###end article-title 63
###begin article-title 64
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
###end article-title 64
###begin article-title 65
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Putative tumor suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status
###end article-title 65
###begin article-title 66
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome
###end article-title 66
###begin article-title 67
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice
###end article-title 67
###begin article-title 68
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Preferential induction of mammary tumors in p53 hemizygous BALB/c mice by fractionated irradiation of a sub-lethal dose of X-rays
###end article-title 68
###begin article-title 69
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
###end article-title 69
###begin article-title 70
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
###end article-title 70
###begin article-title 71
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Atm deficient mice: a paradigm of ataxia telangiectasia
###end article-title 71
###begin article-title 72
###xml 91 97 <span type="species:ncbi:10090">murine</span>
Putative tumor suppressor gene region within 0.85 cM on chromosome 12 in radiation-Induced murine lymphomas
###end article-title 72
###begin article-title 73
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice
###end article-title 73
###begin article-title 74
###xml 48 52 <span type="species:ncbi:10090">mice</span>
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
###end article-title 74
###begin article-title 75
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rapop-1 </italic>
Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop-1 (radiation-induced apoptosis 1)
###end article-title 75
###begin article-title 76
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16
###end article-title 76
###begin article-title 77
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nbn </italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis
###end article-title 77
###begin article-title 78
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p27</italic>
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip1 </italic>
###xml 19 24 19 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip1 </italic></sup>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
The murine gene p27Kip1 is haplo-insufficient for tumor suppression
###end article-title 78
###begin title 79
Figures and Tables
###end title 79
###begin p 80
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 119 126 119 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a, b) </bold>
###xml 179 182 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 200 207 200 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, d) </bold>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 251 255 251 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 258 262 258 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 269 276 269 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e, f) </bold>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 320 324 320 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 324 327 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 338 342 338 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g) </bold>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 391 395 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 402 406 402 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h) </bold>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 430 434 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 437 441 437 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 331 336 <span type="species:ncbi:10090">mouse</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
Histopathology of tumours in (BALB/cHeA x MSM/Ms)F1 mice with genotypes p53+/- Atm+/-, p53+/- Atm+/+ or p53+/+ Atm+/-. (a, b) Spontaneously developing mammary adenocarcinoma from p53+/- Atm+/- mouse. (c, d) Mammary adenocarcinoma from X-irradiated p53+/- Atm+/- mouse. (e, f) Mammary adenocarcinoma from X-irradiated p53+/- Atm+/+ mouse. (g) Osteosarcoma observed in nonirradiated p53+/- Atm+/- mouse. (h) Thymic lymphoma from p53+/+ Atm+/- mouse exposed to X-rays. Panels a, c and e: 40x. Panels b, d, f, g and h: 100x.
###end p 80
###begin p 81
###xml 96 98 96 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 111 115 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 118 122 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Cumulative incidence of mammary carcinomas in irradiated and nonirradiated (BALB/cHeA x MSM/Ms)F1 mice with p53+/- Atm+/- or p53+/- Atm+/+ genotype.
###end p 81
###begin p 82
###xml 70 72 70 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Incidence of tumours developing spontaneously in (BALB/cHeA x MSM/Ms)F1 female mice that were heterozygously deficient for p53 and/or Atm genes
###end p 82
###begin p 83
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
aNumber of mice with tumours. bTotal number of mammary carconomas developing in mice with given genotypes/number of mice examined; numbers in parentheses are average numbers of tumours per mouse.
###end p 83
###begin p 84
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm </italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Incidence of tumours in irradiated (BALB/cHeA x MSM/Ms) F1 female mice that were heterozygously deficient for p53 and/or Atm genes
###end p 84
###begin p 85
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 512 515 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 515 519 515 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 522 526 522 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 532 534 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 547 549 547 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 635 639 635 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 639 642 639 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atm</italic>
###xml 642 646 642 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 424 429 <span type="species:ncbi:10090">mouse</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
aNumber of mice with tumours; percentage in parenthesis is the proportion of mice developing mammary carcinoma. bThree animals developed both lymphomas and mammary carcinoma. cOne animal developed both histiocytic sarcoma and mammary carcinoma. dTumour in abdomen. eTotal number of mammary carcinomas developing in mice with given genotypes/number of mice examined; numbers in parentheses are average numbers of tumours per mouse. *The proportion of mice developing tumours is significantly greater than that in p53+/- Atm+/+ mice (P = 0.0034 by c2 test). **The average number of tumours/mouse is significantly greater than that in p53+/- Atm+/+ mice (P = 0.0052 by Mann-Whitney U-test). NOS, not otherwise specified.
###end p 85

